Search

everythinglearnresearchcommunity

for

Search:↓

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Tofacitinib may help treat hair loss in children with alopecia areata.

Hedgehog pathway inhibitors for advanced basal cell carcinoma can cause side effects, but managing them helps maintain treatment.

Ritlecitinib works well and is safe for treating alopecia areata.

Upadacitinib may effectively treat alopecia areata without side effects.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

These new skin treatments are safer and more effective with minimal side effects.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Minoxidil mixed with β-cyclodextrin improves solubility and gradual release.